Skip Navigation


Hum. Reprod. Advance Access originally published online on October 28, 2004
Human Reproduction 2005 20(1):117-121; doi:10.1093/humrep/deh589
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
20/1/117    most recent
deh589v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Seow, K.-M.
Right arrow Articles by Hwang, J.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seow, K.-M.
Right arrow Articles by Hwang, J.-L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction vol. 20 no. 1 © European Society of Human Reproduction and Embryology 2004; all rights reserved

Serum and follicular resistin levels in women with polycystic ovarian syndrome during IVF-stimulated cycles

Kok-Min Seow1,2, Chi-Chang Juan3,4, Yung-Pei Hsu4, Low-Tone Ho2,3,4,5, Yuan-Yung Wang1 and Jiann-Loung Hwang6,7,8

1 Department of Obstetrics and Gynecology, E-Da Hospital/I-Shou University, Kaohsiung County, 2 Institute of Clinical Medicine and 3 Institute of Physiology, National Yang-Ming University, Taipei, 4 Department of Medical Research & Education and 5 Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, 6 Department of Obstetrics and Gynecology, Shin Kong Wu-Ho-Su Memorial Hospital, Taipei and 7 Department of Obstetrics and Gynecology, Taipei Medical University, Taipei, Taiwan

8 To whom correspondence should be addressed at: Department of Obstetrics and Gynecology, Shin Kong Wu-Ho-Su Memorial Hospital, No. 95, Wen Chang Road, Shih Lin District, Taipei, Taiwan. Email: ed101174{at}edah.org.tw

BACKGROUND: Resistin is a hormone linking obesity and insulin resistance. The aim of this study was to compare resistin levels in serum or follicular fluid from women with polycystic ovarian syndrome (PCOS) and controls, both of whom were undergoing IVF. METHODS: We compared serum and follicular resistin levels in 21 PCOS women and in 18 healthy, normal ovulation, age- and body mass index (BMI)-matched non-PCOS women undergoing IVF. Correlations between serum or follicular fluid resistin levels and reproductive outcome were evaluated. RESULTS: There was no significant difference in either serum or follicular resistin levels between the control group and the PCOS group as a whole or those with insulin resistance [homeostasis model assessment of insulin resistance index applied to oral glucose tolerance test (HOMAOGTT) <4.7]. However, resistin levels in follicular fluid were unexpectedly significantly lower than serum levels (P<0.0001) in both the PCOS and control groups. No significant correlation was found between resistin levels and BMI, estradiol, LH, or fasting or 2 h glucose or insulin levels or between follicular resistin levels and fertilization rate, implantation rate, clinical pregnancy rate, or early miscarriage rate in PCOS. CONCLUSION: Resistin is unlikely to be a major determining factor in the growth and maturation of oocytes during IVF-stimulated cycles in PCOS.

Key words: follicular fluid/IVF/polycystic ovarian syndrome/resistin


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
A Majuri, M Santaniemi, K Rautio, A Kunnari, J Vartiainen, A Ruokonen, Y A Kesaniemi, J S Tapanainen, O Ukkola, and L Morin-Papunen
Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study
Eur. J. Endocrinol., February 1, 2007; 156(2): 263 - 269.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
G. G. Gosman, H. I. Katcher, and R. S. Legro
Obesity and the role of gut and adipose hormones in female reproduction
Hum. Reprod. Update, September 1, 2006; 12(5): 585 - 601.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
H.F. Escobar-Morreale, G. Villuendas, J.I. Botella-Carretero, F. Alvarez-Blasco, R. Sanchon, M. Luque-Ramirez, and J.L. San Millan
Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study
Hum. Reprod., September 1, 2006; 21(9): 2257 - 2265.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
M Mitchell, D T Armstrong, R L Robker, and R J Norman
Adipokines: implications for female fertility and obesity
Reproduction, November 1, 2005; 130(5): 583 - 597.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.